查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494624

胃腸道藥物市場：按類型、疾病類型、給藥途徑、分銷管道、最終用戶分類 - 全球預測 2024-2030

Gastrointestinal Agents Market by Type (Dietary Supplements, Drugs), Disease Type (Constipation, Diarrhea, Gastroesophageal Reflux Disease), Route of Administration, Distribution Channel, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年胃腸道藥物市場規模為572.6億美元，預計2024年將達600.6億美元，2030年將達804.7億美元，複合年成長率為4.97%。

胃腸道藥物是一類旨在治療影響胃腸道（包括胃和腸道）的各種疾病的藥物。這些病症包括胃酸逆流和潰瘍、大腸激躁症和克隆氏症。這些藥物的主要作用是改善腸道功能、緩解症狀以及控制或治療潛在的胃腸道疾病。隨著胃食道逆流、消化性潰瘍和發炎性腸道疾病（IBD）等胃腸道疾病在世界各地呈上升趨勢，需要有效的胃腸道藥物。發展中地區胃腸道健康意識的提高和衛生服務的改善也有助於擴大胃腸道藥物的使用。胃腸道藥物的高治療成本和抗藥性問題正在阻礙市場成長。胃腸病學的持續研究和開發預計將帶來更有效、更安全的藥物的推出，為胃腸道藥物市場創造機會。

主要市場統計
基準年[2023] 572.6億美元
預測年份 [2024] 600.6億美元
預測年份 [2030] 804.7億美元
複合年成長率（%） 4.97%

區域洞察

美洲地區先進的醫療體系、人們對胃腸道疾病的認知度高以及對醫療保健的高投入，使得胃腸道藥物市場得到了極大的開拓。胃腸道疾病的高盛行率和製藥公司的強大存在構成了胃腸道藥物市場的基礎。在南美洲，醫療基礎設施的改善和醫療保險覆蓋率的擴大正在逐步提振市場。在亞太地區，人口成長、醫療成本上升以及人們對胃腸道疾病的認知不斷提高，正在推動胃腸道藥物市場的快速成長。日本、中國和印度等國家在這一成長中處於領先地位，因為它們人口眾多，中階不斷壯大，並且可以輕鬆獲得醫療保健服務。此外，由於飲食向西式轉變，亞太地區胃腸道疾病的盛行率正在增加。歐洲是全球胃腸道藥物市場的主要地區，擁有先進的醫療體系和較高的胃腸道疾病盛行率。監管支持和大型製藥公司的存在也促進了該市場的成長。雖然波灣合作理事會(GCC) 國家因其發達的醫療基礎設施而具有較高的市場滲透率，但非洲其他地區是新興市場，獲得醫療服務的機會有限。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在胃腸道藥物市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對胃腸道藥物市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他關鍵指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對當前胃腸道藥物市場地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球胃腸道疾病盛行率增加
      • 關於胃腸道健康和可用治療方法的教育宣傳活動
      • 健康保險範圍和報銷政策的有利變化
    • 抑制因素
      • 藥品生產所需原料供應中斷
    • 機會
      • 政府核准治療胃腸道疾病的新藥
      • 持續研究並開發創新藥物配方和輸送系統
    • 任務
      • 與胃腸道藥物和補充品相關的副作用
  • 市場區隔分析
    • 類型：隨著越來越注重健康的消費者的增加，營養食品的使用也增加。
    • 最終用戶：作為初始患者治療和持續管理計劃的一部分，醫院和診所胃腸道藥物的巨大潛力
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章胃腸道藥物市場：按類型

  • 膳食食品
  • 藥品

第7章胃腸道藥物市場：依疾病類型

  • 便秘
  • 腹瀉
  • 胃食道逆流症
  • 發炎性腸道疾病
  • 大腸激躁症
  • 消化性潰瘍

第8章胃腸道藥物市場：依給藥途徑分類

  • 口服
  • 胃腸外的
  • 直腸

第9章胃腸道藥物市場：依分銷管道分類

  • 線下藥局
  • 網路藥房

第10章胃腸道藥物市場：依最終使用者分類

  • 居家護理
  • 醫院/診所

第11章 北美洲和南美胃腸道藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太胃腸道藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲胃腸道藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Calm & Focus 簡介：PLT Health Solutions 基於 Zembrin 和 GABA 的膳食食品
    • Designs for Health 推出有益於女性健康的創新益生菌
    • 在 Target 商店推出 Wonder Berry 限量口味制酸劑
  • 戰略分析和建議

第15章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-CB04E056533F

[195 Pages Report] The Gastrointestinal Agents Market size was estimated at USD 57.26 billion in 2023 and expected to reach USD 60.06 billion in 2024, at a CAGR 4.97% to reach USD 80.47 billion by 2030.

Gastrointestinal agents are a category of medications designed to treat various conditions that affect the gastrointestinal tract, which includes the stomach and intestines. These conditions range from acid reflux and ulcers to irritable bowel syndrome and Crohn's disease. The primary role of these agents is to improve gut function, relieve symptoms, and manage or cure underlying GI disorders. The rise in gastrointestinal diseases around the world, including conditions such as gastroesophageal reflux disease, peptic ulcers, and inflammatory bowel disease (IBD), drives the need for effective gastrointestinal agents. Growing awareness about gastrointestinal health and improved access to healthcare services in developing regions also contribute to the expanded use of GI agents. High treatment costs and drug resistance issues with gastrointestinal agents hamper the market growth. Ongoing research and development in gastroenterology led to introduction of more effective and safer drugs, which are expected to create opportunities for gastrointestinal agent market.

KEY MARKET STATISTICS
Base Year [2023] USD 57.26 billion
Estimated Year [2024] USD 60.06 billion
Forecast Year [2030] USD 80.47 billion
CAGR (%) 4.97%

Regional Insights

In the Americas, the gastrointestinal agents market is highly developing due to advanced healthcare systems, high awareness of gastrointestinal disorders, and substantial investments in healthcare. The higher prevalence of gastrointestinal diseases and the strong presence of pharmaceutical companies create a platform for the gastrointestinal agents market. In South America, improvements in healthcare infrastructure and increased health insurance coverage are gradually boosting the market. The APAC region is seeing rapid growth in the gastrointestinal agents market driven by increasing population, rising healthcare expenditures, and growing awareness of gastrointestinal disorders. Countries such as Japan, China, and India are leading this growth due to their large populations and increasing middle class, which has better access to healthcare services. Additionally, Asia-Pacific is experiencing a shift towards Western diets, increasing the prevalence of gastrointestinal issues. Europe is a major region in the global gastrointestinal agents market, with advanced healthcare systems and a high prevalence of gastrointestinal diseases. Regulatory support and the presence of major pharmaceutical companies also contribute to the growth of this market. The Gulf Cooperation Council (GCC) countries show higher market penetration due to better healthcare infrastructure, while other parts of Africa are emergent markets with limited access to healthcare.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Gastrointestinal Agents Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing prevalence of gastrointestinal disorders across the globe
      • Educational campaigns about gastrointestinal health and available treatments
      • Favorable changes in health insurance coverage and reimbursement policies
    • Market Restraints
      • Disruptions in the supply of raw materials required for drug manufacturing
    • Market Opportunities
      • Government approvals for new therapeutic agents to treat gastrointestinal disorders
      • Ongoing research and development aimed at innovative drug formulations and delivery systems
    • Market Challenges
      • Side effects associated with gastrointestinal drugs and supplements
  • Market Segmentation Analysis
    • Type: Growing usage of dietary supplements with an increasing number of health-conscious consumers
    • End-User: High potential of gastrointestinal agents across hospitals & clinics as part of initial treatment and ongoing management plans for patients
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Gastrointestinal Agents Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Gastrointestinal Agents Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Introduction of Calm & Focus: A Zembrin and GABA-Based Dietary Supplement by PLT Health Solutions

PLT Health Solutions, in collaboration with Now, has launched 'Calm & Focus with Zembrin & GABA', a new dietary supplement formulated for cognitive enhancement. This product incorporates Zembrin, a patented extract of the South African plant Sceletium tortuosum, traditionally used by the Khoi-San people for mood enhancement and stress reduction. The supplement is designed to offer rapid benefits, promoting alertness, serene focus, and improved mental functionality through the combined effects of Zembrin and GABA, ensuring a balanced approach to stress management and cognitive support. [Published On: 2023-11-17]

Innovative Women's Health Probiotics Launched by Designs for Health

Designs for Health has introduced two new products tailored for women's health across different life stages. The first, ProbioMed Women, is a daily probiotic supplement containing 25 billion CFUs from 10 clinically researched strains. This formulation is engineered to support vaginal pH, microflora balance in the vagina, and gastrointestinal microbial equilibrium. [Published On: 2023-08-17]

Market Introduction of Wonderbelly Antacid with Exclusive Flavor at Target Stores

Wonderbelly, an Austin, Texas-based company, is launching its FDA-regulated Wonderbelly Antacid in select Target stores, featuring a Target-exclusive flavor, Fruity Cereal. The product line, designed to alleviate heartburn, acid indigestion, and sour stomach, includes Strawberry Milkshake and Watermelon Mint flavors. This introduction aims to attract customers seeking effective over-the-counter digestive solutions with appealing flavor options. [Published On: 2023-03-27]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Gastrointestinal Agents Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Gastrointestinal Agents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, American Health, Amway Corporation, Archer-Daniels-Midland Company, ARKOPHARMA Laboratories, Company Limited, Bayer AG, Biomedical Research Laboratories, LLC, DuPont de Nemours, Inc., Dymatize Enterprises LLC, FANCL Corporation, Glanbia PLC, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Himalaya Wellness Company, Nature's Sunshine Products, Inc., Nestle S.A, Nutraceutical International Corporation, NutraScience Labs, Otsuka Holdings Co. Ltd., Pfizer Inc., Pragati Biocare Pvt. Ltd.,, Procter & Gamble Health Limited, Pure Encapsulations, LLC., Sabinsa Corporation, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Gastrointestinal Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Dietary Supplements
    • Drugs
      • Antacids
      • Anti-diarrheal Agents
      • Anti-emetics
      • H2 Blockers
      • Laxatives
      • Proton Pump Inhibitors
  • Disease Type
    • Constipation
    • Diarrhea
    • Gastroesophageal Reflux Disease
    • Inflammatory Bowel Disease
    • Irritable Bowel Syndrome
    • Peptic Ulcer Disease
  • Route of Administration
    • Oral
    • Parenteral
    • Rectal
  • Distribution Channel
    • Offline Pharmacies
    • Online Pharmacies
  • End-User
    • Homecare
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of gastrointestinal disorders across the globe
      • 5.1.1.2. Educational campaigns about gastrointestinal health and available treatments
      • 5.1.1.3. Favorable changes in health insurance coverage and reimbursement policies
    • 5.1.2. Restraints
      • 5.1.2.1. Disruptions in the supply of raw materials required for drug manufacturing
    • 5.1.3. Opportunities
      • 5.1.3.1. Government approvals for new therapeutic agents to treat gastrointestinal disorders
      • 5.1.3.2. Ongoing research and development aimed at innovative drug formulations and delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Side effects associated with gastrointestinal drugs and supplements
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of dietary supplements with an increasing number of health-conscious consumers
    • 5.2.2. End-User: High potential of gastrointestinal agents across hospitals & clinics as part of initial treatment and ongoing management plans for patients
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Gastrointestinal Agents Market, by Type

  • 6.1. Introduction
  • 6.2. Dietary Supplements
  • 6.3. Drugs

7. Gastrointestinal Agents Market, by Disease Type

  • 7.1. Introduction
  • 7.2. Constipation
  • 7.3. Diarrhea
  • 7.4. Gastroesophageal Reflux Disease
  • 7.5. Inflammatory Bowel Disease
  • 7.6. Irritable Bowel Syndrome
  • 7.7. Peptic Ulcer Disease

8. Gastrointestinal Agents Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral
  • 8.4. Rectal

9. Gastrointestinal Agents Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline Pharmacies
  • 9.3. Online Pharmacies

10. Gastrointestinal Agents Market, by End-User

  • 10.1. Introduction
  • 10.2. Homecare
  • 10.3. Hospitals & Clinics

11. Americas Gastrointestinal Agents Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Gastrointestinal Agents Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Gastrointestinal Agents Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Introduction of Calm & Focus: A Zembrin and GABA-Based Dietary Supplement by PLT Health Solutions
    • 14.3.2. Innovative Women's Health Probiotics Launched by Designs for Health
    • 14.3.3. Market Introduction of Wonderbelly Antacid with Exclusive Flavor at Target Stores
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. GASTROINTESTINAL AGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. GASTROINTESTINAL AGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GASTROINTESTINAL AGENTS MARKET DYNAMICS
  • FIGURE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. GASTROINTESTINAL AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. GASTROINTESTINAL AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTACIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-DIARRHEAL AGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-DIARRHEAL AGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-EMETICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ANTI-EMETICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY LAXATIVES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PROTON PUMP INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY CONSTIPATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIARRHEA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DIARRHEA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY IRRITABLE BOWEL SYNDROME, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PEPTIC ULCER DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY RECTAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOMECARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL AGENTS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES GASTROINTESTINAL AGENTS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL AGENTS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK GASTROINTESTINAL AGENTS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT GASTROINTESTINAL AGENTS MARKET SIZE, BY DIST